跳至主要内容
临床试验/CTRI/2024/12/077830
CTRI/2024/12/077830尚未招募不适用

ASSESSING THE EFFECT OF AMBROSIA ARTEMISIAEFOLIA AND INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF ALLERGIC RHINITIS IN ADULT POPULATION: A COMPARATIVE RANDOMIZED CLINICAL STUDY

Principal Bakson Homoeopathic medical college and hospital1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2024年12月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
68
试验地点
1
主要终点
Decrease in TNSS Scale to signify improvement in Allergic Rhinitis.

研究概览

简要总结

This is a randomized comparative parallel arm study, to compare the effect of Ambrosia and individualized homoeopathic medicines in the management of Allergic Rhinitis by using TNSS scale. The primary outcome is to assess the change in TNSS scale in both groups at baseline and after treatment period of 6 months.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 59.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed participants(new and old) of Allergic Rhinitis.
  • Participants from 20–59 years age group, both male and female.
  • Participants who had taken any Anti – allergic medicines for Allergic Rhinitis willing to have homoeopathic treatment will be enrolled after washout period of 2 weeks.
  • New cases of allergic rhinitis will be diagnosed by clinical and physical examination .

排除标准

  • Participants with other Upper respiratory tract infection (Laryngitis, Pharyngitis, Diphtheria, Etc.) Participants with Lower respiratory tract infection (Chronic bronchitis, Bronchial Asthma, Pulmonary Tuberculosis) Gross nasal developmental defects or structural abnormalities causing obstruction, e.g., nasal polyp(s), deviated septum etc.
  • Participants on steroid treatment.
  • Pregnant and Lactating females.

结局指标

主要结局

Decrease in TNSS Scale to signify improvement in Allergic Rhinitis.

时间窗: TNSS Scale will be used at baseline, every 4 weeks upto 24 weeks. | 15 month study. | 6 months enrolment | 6 months follow up | 3months analysis | first dose at the time of case taking and subsequent doses according to follow ups.

次要结局

未报告次要终点

研究者

发起方
Principal Bakson Homoeopathic medical college and hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Bhavana Sengar

Bakson homoeopathic medical college and hospital

研究点 (1)

Loading locations...

相似试验